TGF-β1 siRNA effectively reduces high-glucose-induced TGF-β1, PAI-1, and collagen type I mRNA, and protein expression in kidney and liver fibrosis [13,14,15], and its application in vascular pathologies deserves further investigation. This evidence concerns the gene TGFB1 and Hepatic fibrosis.